MRCL
Showing 1 - 8 of 8
Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle
Recruiting
- Metastatic Leiomyosarcoma
- +17 more
- Itacitinib
- Laboratory Biomarker Analysis
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 13, 2022
Ovarian Cancer, NSCLC, ESCC Trial in United States (ASP0739, Pembrolizumab)
Active, not recruiting
- Ovarian Cancer
- +3 more
-
Duarte, California
- +6 more
Jan 21, 2023
Multiple Myeloma, Melanoma, Synovial Sarcoma Trial in Philadelphia (biological, drug, device)
Terminated
- Multiple Myeloma
- +3 more
- NY-ESO-1 redirected autologous T cells with CRISPR edited endogenous TCR and PD-1
- +3 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Oct 9, 2020
Sarcoma, Melanoma, NSCLC Trial in United States (CMB305, G100, Metronomic CPA)
Terminated
- Sarcoma
- +3 more
- CMB305
- +2 more
-
Santa Monica, California
- +7 more
Jun 29, 2020
Myxoid Liposarcoma, Round Cell Liposarcoma, Synovial Sarcoma Trial in Seattle (Laboratory Biomarker Analysis, Recombinant
Terminated
- Myxoid Liposarcoma
- +2 more
- Laboratory Biomarker Analysis
- Recombinant Interferon Gamma
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 19, 2019
Recurrent Childhood Acute Lymphoblastic Leukemia Trial in Worldwide (L-asparaginase, doxorubicin HCl, therapeutic
Completed
- Recurrent Childhood Acute Lymphoblastic Leukemia
- L-asparaginase
- +13 more
-
Birmingham, Alabama
- +45 more
Nov 14, 2017
Adult Liposarcoma, Adult Synovial Sarcoma, Recurrent Adult Soft Tissue Sarcoma Trial in Seattle (drug, biological, other)
Completed
- Adult Liposarcoma
- +4 more
- cyclophosphamide
- +2 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Dec 9, 2014
Liposarcoma,Myxoid Trial in France, Germany, United States (Trabectedin, Dexamethasone)
Completed
- Liposarcoma,Myxoid
-
Coeur D Alene, Idaho
- +7 more
Apr 22, 2014